06.27.26 -- Oral Solid Dose Contract Manufacturing Services

Global demand for solid dose manufacturing brings both scale and complexity. Our solid forms plant exports 75% of its output, supplying products to 45 markets in 25 different languages.

Drug delivery strategy drives effectiveness and outcomes. Advances in formulation and dosing enable precise, scalable solutions to overcome development challenges and boost performance.

GMP drug product manufacturing supports solid dose and sterile parenteral development with formulation expertise, isolator fill‑finish, DEA‑licensed work, packaging, labeling, and supply‑chain services.

Solve the unique challenges of poorly soluble molecules like targeted protein degraders (TPDs), such as PROTACs and molecular glues, seamlessly accelerating your molecule from development to commercialization.

Achieve commercial readiness with flexible, compliant, and scalable drug product manufacturing. Solutions support solid oral dosage forms and high-potency handling for global markets and niche indications.

Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.

Closed systems, specialized facilities, and flexible batch approaches work together to reduce risk. Learn how these strategies enable dependable supply while maintaining quality across development.

Expanded capacity and targeted investment are enabling more agile scale-up, stronger formulation capabilities, and faster timelines—helping teams navigate complex therapies with greater precision.

Want to improve API performance? Discover how using mesoporous silica as a means to enhance the micronization process is redefining the path to more efficient and reliable API formulation.

Structured workflows bring clarity to solid form selection. We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each program.

A global, integrated approach to oral solid dosage development combines formulation science, advanced delivery, and scalable manufacturing to support efficient clinical progress and reliable supply.

Small molecule drugs dominate modern medicine thanks to their ability to absorb quickly. Their size and chemistry make them both highly effective and convenient for patients across many therapeutic areas.

Multiparticulates enable tailored drug release with improved flexibility and dose accuracy, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.

An integrated development and manufacturing approach that cuts handoffs, manages risk, and accelerates timelines by uniting formulation, analytics, production, and packaging.

Explore how integrated expertise across oral, nasal, pulmonary, and sterile drug products supports efficient development and manufacturing, helping teams streamline timelines.